Sulfonamides having antiangiogenic and anticancer activity
US7491718B2 · kind B2 · utility
25Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2003 |
| Grant date | Feb 17, 2009 |
| Priority date | — |
| Expiry date | Dec 28, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D231/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.